HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

W E R Ollier Selected Research

Autoantibodies

10/2015Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes.
10/2009Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis.
6/2009Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.
10/2008The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients.
12/2007HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


W E R Ollier Research Topics

Disease

7Genetic Predisposition to Disease (Genetic Predisposition)
08/2007 - 02/2002
6Dermatomyositis (Dermatopolymyositis)
10/2015 - 04/2007
6Keloid
04/2010 - 06/2002
5Myositis (Idiopathic Inflammatory Myopathies)
10/2015 - 09/2007
5Cicatrix (Scar)
04/2010 - 02/2004
5Giant Cell Arteritis (Horton Disease)
01/2007 - 03/2002
4Erythema Nodosum
01/2009 - 03/2004
4Fibrosis (Cirrhosis)
10/2005 - 03/2002
3Necrosis
04/2008 - 05/2006
3Rheumatoid Arthritis
05/2007 - 03/2004
3Disease Susceptibility (Diathesis)
04/2007 - 01/2004
3Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
01/2004 - 03/2002
3Aphthous Stomatitis (Aphthous Ulcer)
11/2003 - 08/2002
3Dupuytren Contracture (Dupuytrens Contracture)
06/2003 - 02/2002
2Polymyositis
10/2015 - 09/2007
2Bacterial Infections (Bacterial Infection)
08/2007 - 06/2006
2Sepsis (Septicemia)
08/2007 - 06/2006
2Multiple Sclerosis
05/2006 - 08/2004
1Diabetes Mellitus
10/2020
1Weight Loss (Weight Reduction)
06/2013
1Type 2 Diabetes Mellitus (MODY)
06/2013
1Periodontitis
03/2011
1Aggressive Periodontitis (Periodontosis)
03/2011
1Periodontal Diseases (Periodontal Disease)
03/2011
1Rupture
01/2011
1Calcinosis
06/2009
1Joint Diseases (Joint Disease)
02/2009
1Connective Tissue Diseases (Connective Tissue Disease)
09/2007
1Osteoarthritis
08/2007
1Myocardial Ischemia (Ischemic Heart Diseases)
05/2007
1Neoplasms (Cancer)
05/2007
1Hemolytic Anemia
12/2006
1Purpura
09/2006
1Vascular Skin Diseases
09/2006
1Cutaneous Leukocytoclastic Vasculitis (Hypersensitivity Angiitis)
09/2006
1Dog Diseases (Disease, Canine)
01/2005
1Feline Infectious Peritonitis
04/2004
1Sarcoidosis (Schaumann Disease)
03/2004
1Virus Diseases (Viral Diseases)
10/2003
1Behcet Syndrome (Behcet's Syndrome)
07/2003
1Asthma (Bronchial Asthma)
12/2002
1Ataxia Neuropathy Spectrum
11/2002
1Vasculitis (Vasculitides)
07/2002
1Nut Hypersensitivity (Nut Allergy)
06/2002
1Infections
03/2002

Drug/Important Bio-Agent (IBA)

6CytokinesIBA
03/2011 - 03/2002
5AutoantibodiesIBA
10/2015 - 12/2007
5DNA (Deoxyribonucleic Acid)IBA
01/2011 - 03/2002
5Transforming Growth Factor beta (TGF-beta)IBA
10/2005 - 02/2002
4HLA-DRB1 Chains (HLA DRB1)IBA
04/2010 - 05/2007
4Interleukin-6 (Interleukin 6)IBA
05/2008 - 03/2002
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2007 - 05/2002
3AntigensIBA
10/2020 - 12/2006
3Interleukin-1 (Interleukin 1)IBA
03/2011 - 05/2002
3Histocompatibility Antigens Class IIIBA
10/2009 - 04/2004
3Biological ProductsIBA
08/2007 - 03/2004
2HLA-B Antigens (HLA-B)IBA
10/2015 - 09/2007
2AntibodiesIBA
06/2009 - 09/2007
2Peptides (Polypeptides)IBA
01/2009 - 01/2007
2Matrix Metalloproteinases (MMPs)IBA
08/2007 - 03/2004
2Calcitriol Receptors (Calcitriol Receptor)IBA
08/2007 - 11/2002
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
07/2007 - 09/2004
2E-SelectinIBA
03/2004 - 07/2002
2Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
02/2004 - 06/2003
2VaccinesIBA
10/2003 - 03/2002
1Histidine-tRNA LigaseIBA
10/2015
1Jo-1 antibodyIBA
10/2015
1HLA-DRB1*03:01 antigenIBA
10/2015
1Insulin-Like Growth Factor II (Somatomedin A)IBA
06/2013
1AutoantigensIBA
10/2009
1EnzymesIBA
10/2009
1UbiquitinIBA
10/2009
1Proteins (Proteins, Gene)FDA Link
06/2009
1Chemokine CCL5IBA
01/2009
1Protein Tyrosine PhosphatasesIBA
10/2008
1RNA (Ribonucleic Acid)IBA
04/2008
1Polyethylene (Polythene)IBA
08/2007
1InterleukinsIBA
08/2007
1Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
08/2007
1EpitopesIBA
05/2007
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
04/2007
1Genetic Markers (Genetic Marker)IBA
04/2007
1Macrophage Migration-Inhibitory FactorsIBA
09/2006
1OsteoprotegerinIBA
06/2006
1Apolipoproteins E (ApoE)IBA
05/2006
1Protein Isoforms (Isoforms)IBA
10/2005
1Protein Kinase C-alphaIBA
08/2004
1Matrix Metalloproteinase 3 (Stromelysin 1)IBA
03/2004
1Interferon-gamma (Interferon, gamma)IBA
01/2004
1Interleukin-10 (Interleukin 10)IBA
11/2003
1Interleukin-12 (IL 12)IBA
11/2003
1Dichlororibofuranosylbenzimidazole (DRB)IBA
10/2003
1Chemokine ReceptorsIBA
12/2002
1Lymphotoxin-alpha (Lymphotoxin)IBA
11/2002
13' Untranslated Regions (3' UTR)IBA
06/2002
1Transforming Growth Factor beta1 (TGF beta 1)IBA
03/2002
1Corticotropin-Releasing HormoneIBA
03/2002

Therapy/Procedure

2Hip Replacement Arthroplasty (Total Hip Replacement)
08/2007 - 06/2006
1Arthroplasty
06/2006